Testosterone therapy is not routinely recommended for postmenopausal women, in part because long-term safety data remain limited. It is, however, prescribed off label to help women suffering from low libido. A new study links testosterone therapy in postmenopausal women with a higher risk of incident cardiovascular disease. Results of the study were presented at the 2026 Annual Meeting of The Menopause Society in San Diego, Oct. 20–24, 2026.
❓ Unknown
Study Links Testosterone Therapy to Increased Cardiovascular Risk in Postmenopausal Women
1w ago
October 20, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
A study presented at the 2026 Annual Meeting of The Menopause Society indicates that testosterone therapy may increase the risk of cardiovascular disease in postmenopausal women. This therapy is often prescribed off label for low libido despite limited long-term safety data. The findings could impact healthcare practices in Iran regarding women's health treatments.
🔍 Quick Context Guide
💡 Bottom Line:
New research raises concerns about the safety of testosterone therapy for postmenopausal women, potentially reshaping treatment protocols.
👥 Key Players
The Menopause Society
MENTIONED
Professional organization for menopause research
"They are influential in shaping guidelines and recommendations for women's health, including hormone therapies."
Healthcare providers
MENTIONED
Doctors and specialists prescribing testosterone therapy
"They play a crucial role in implementing treatment options and ensuring patient safety."
📰 What Happened
A study presented at a major conference indicates that testosterone therapy may increase cardiovascular disease risk in postmenopausal women. This therapy is often used off-label for low libido despite concerns about its long-term safety.
- Testosterone therapy is not routinely recommended for postmenopausal women due to limited long-term safety data.
- The study's findings could lead to changes in how testosterone therapy is prescribed in the future.
💡 Why It Matters
🇮🇷 For Iran: The findings could impact healthcare practices in Iran, where women's health treatments are evolving, and may lead to more cautious approaches to hormone therapy.
🌍 Regional: In the broader Middle East, this research may influence women's health policies and treatment options across various countries.
🌐 International: Globally, this study could affect the acceptance and regulation of testosterone therapy for women, prompting further research and discussion.
📚 Background
Testosterone therapy is sometimes used to address low libido in postmenopausal women, but its safety profile is still under scrutiny. Understanding the risks associated with hormone therapies is crucial for informed healthcare decisions.
Hormone replacement therapy
Women's health in menopause
📡 Source:
NEUTRAL
📊 Confidence:
70%
The information is derived from a scientific study presented at a reputable medical conference, suggesting a focus on evidence-based findings.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
14 min ago •
Exploring the Challenges and Issues of Sports Committees in North Khorasan
15 min ago •
Vaccine Production Infrastructure at 'Razi' and 'Pasteur' Needs Renovation
16 min ago •
Yellow Weather Warning Issued for Scattered Showers in Fars/ Temperature Drop from Monday Evening
16 min ago •
Mahmoudabad Roads Await Repair: From Worn Asphalt to Incomplete Projects
17 min ago •